You have matched to 1 trial

Guest Profile:  No profile selected

Copy link
Sort by zip code: 94107 Hide Map Icon
mail-icon

Register to sign up for Trial Alerts

Receive emails about new trials that match your profile.
1

PET/CT Scan with 18F-Fluciclovine for Metastatic Breast Cancer with Brain Metastases

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Purpose: To study the ability of PET/CT scans with 18F-fluciclovine to identify brain metastases.

Who is this for?: People with metastatic (stage IV) breast cancer that is suspected or confirmed to have spread to the brain (brain metastasis) who are planning to receive surgery or radiation for the brain metastases. View full eligibility criteria

What's involved?

<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">PET/CT scan with 18F-fluciclovine, by IV, 1-3 times</li></ul>

What's being studied?

<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">18F-fluciclovine is an experimental tracer for imaging scans that may help locate cancer in the body.</li> <li class="seamTextUnorderedListItem">A positron emission tomography (PET) scan is an imaging test that uses a radioactive substance called a tracer that can look for and attach to cancer cells.</li> <li class="seamTextUnorderedListItem">A computed tomography (CT) scan produces body pictures created by x-ray energy.</li> <li class="seamTextUnorderedListItem">On a brain PET/CT scan, it can be difficult to tell the difference between cancer progression and cancer cells that have been killed by treatment.</li> <li class="seamTextUnorderedListItem">This study is testing whether 18F-fluciclovine, a tracer, can help with this.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>

How can I learn more?

<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06055790' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://mbcbrainmets.org/' target='_blank'>MBCBrainMets.org</a> </li></ul>
1

PET/CT Scan with 18F-Fluciclovine for Metastatic Breast Cancer with Brain Metastases

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
Icon

Nearest Location:
752 miles
Arizona Cancer Center at UMC North/University Medical Center
Tucson, AZ

Icon

Visits:
1-3 visits

Icon

ClinicalTrials.gov: NCT06055790

Icon

Phase II

HELP GUIDE
HELP GUIDE